Last reviewed · How we verify
Mylan generic fentanyl TDS — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Mylan generic fentanyl TDS (Mylan generic fentanyl TDS) — University of Maryland, Baltimore.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Mylan generic fentanyl TDS TARGET | Mylan generic fentanyl TDS | University of Maryland, Baltimore | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Mylan generic fentanyl TDS CI watch — RSS
- Mylan generic fentanyl TDS CI watch — Atom
- Mylan generic fentanyl TDS CI watch — JSON
- Mylan generic fentanyl TDS alone — RSS
Cite this brief
Drug Landscape (2026). Mylan generic fentanyl TDS — Competitive Intelligence Brief. https://druglandscape.com/ci/mylan-generic-fentanyl-tds. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab